|
市場調査レポート
商品コード
1298635
不妊治療サービス市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測Fertility Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
不妊治療サービス市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測 |
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
世界の不妊治療サービス市場規模は、2022年に352億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて15.5%の成長率(CAGR)を示し、2028年までに840億米ドルに達すると予測しています。
不妊治療サービスとは、不妊症の治療として提供される処置を指します。不妊症とは、妊娠できないこと、または妊娠を継続できないことと定義されます。男性では、精子の数が少ないか、ホルモンのアンバランスの結果として特定されます。女性の場合、不妊症とは、卵巣から卵子が放出されるきっかけとなる脳内ホルモンを刺激する視床下部や下垂体などの分泌腺が適切に機能していないことを指します。不妊治療には、妊娠の可能性を高める薬や処置が含まれます。不妊治療には、排卵誘発剤、人工授精、体外受精(IVF)、卵子凍結または卵子凍結保存、代理出産、生殖補助医療(ART)などが含まれます。不妊カップル、シングルペアレント、LGBTコミュニティのメンバーの家族計画を支援しています。
キャリア志向の人口基盤の拡大は、妊娠遅延の有病率の増加につながり、市場成長に大きく寄与しています。高額な育児サービス、学業やキャリアへの意欲、経済的な安定性の欠如などの懸念から、人々はしばしば、より成熟し経済的に確立された人生の後半に子どもを持つことを選択します。しかし、過度の仕事量とそれに伴うストレス、喫煙や薬物の摂取を含む座りがちな生活習慣が、多くの人々の不妊問題につながっています。さらに、不妊症の原因となる子宮内膜結核、多嚢胞性卵巣症候群(PCOS)、性感染症(STD)などの様々な医学的疾患の有病率の上昇も、市場の成長を促進すると予測されています。さらに、先進経済諸国と新興経済諸国の両方において、個人間の意識の高まりと、改善されたヘルスケア施設へのアクセスの向上が、これらのサービスの採用をさらに増加させています。また、可処分所得の増加や健康保険会社が提供する柔軟な適用範囲とともに、テレビやオンラインポータルサイトでの不妊治療サービスの広告・宣伝の増加といったその他の要因も、市場の成長を後押ししています。
The global fertility services market size reached US$ 35.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 84.0 Billion by 2028, exhibiting a growth rate (CAGR) of 15.5% during 2023-2028.
Fertility services refer to the procedures provided as a treatment for infertility. Infertility is defined as the inability to conceive or carry a full-term pregnancy. Among males, it is identified by a low sperm count or is a result of hormonal imbalance in men. For females, infertility refers to the lack of proper functioning of glands such as hypothalamus and pituitary gland that stimulate hormones in the brain to trigger the ovaries to release an egg. Fertility treatments include medications and procedures that increase the chances of pregnancy. They involve fertility drugs, artificial insemination, In Vitro Fertilization (IVF), egg-freezing or oocyte cryopreservation, surrogacy, Assisted Reproductive Technology (ART) procedures, etc. They assist infertile couples, single parents and members of the LGBT community to plan a family.
The expanding career-oriented population base has led to the increasing prevalence of delayed pregnancies, which is contributing significantly to the market growth. Owing to concerns such as expensive childcare services, academic or career ambitions, and a lack of financial stability, people often opt to have children late in life when they are more mature and financially established. However, excessive workload and the accompanying stress along with sedentary lifestyle habits including smoking and consumption of drugs lead to infertility issues among many of them. Moreover, the rising prevalence of various medical ailments such as endometrial tuberculosis, polycystic ovarian syndrome (PCOS) and sexually transmitted diseases (STDs) that can cause infertility, is also projected to catalyze the growth of the market. Additionally, growing awareness among individuals and increasing accessibility to improved healthcare facilities have further increased the adoption of these services in both developed and emerging economies. Other factors such as increasing advertising and promotion of fertility services on televisions and online portals along with the rising disposable incomes and flexible coverage offered by health insurance companies are also augmenting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global fertility services market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on cause of infertility, procedure, service and end-user.
The report has also analysed the competitive landscape of the market with some of the key players being Instituto Bernabeu Group, INVO Bioscience, Inc., Monash IVF Group, Apollo Hospitals Enterprise Ltd., CARE Fertility Group Ltd., Carolinas Fertility Institute, Genea Limited, The Cooper Companies, Inc., Virtus Health Group, Vitrolife Sweden AB, The Johns Hopkins Health System Corporation, Medicover AB (publ), OvaScience, Inc., Progyny, Inc., and Xytex Corporation.
IMARC Group's latest report provides a deep insight into the global fertility services market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the fertility services market in any manner.